Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease.

Behboudi S, Alisa A, Boswell S, Anastassiou J, Pathan AA, Williams R.

Br J Cancer. 2010 Feb 16;102(4):748-53. doi: 10.1038/sj.bjc.6605526. Epub 2010 Jan 19.

2.

Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients.

Alisa A, Ives A, Pathan AA, Navarrete CV, Williams R, Bertoletti A, Behboudi S.

Clin Cancer Res. 2005 Sep 15;11(18):6686-94.

3.

Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma.

Ritter M, Ali MY, Grimm CF, Weth R, Mohr L, Bocher WO, Endrulat K, Wedemeyer H, Blum HE, Geissler M.

J Hepatol. 2004 Dec;41(6):999-1007.

PMID:
15582134
5.

Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCC.

Greten TF, Ormandy LA, Fikuart A, Höchst B, Henschen S, Hörning M, Manns MP, Korangy F.

J Immunother. 2010 Feb-Mar;33(2):211-8. doi: 10.1097/CJI.0b013e3181bb499f.

PMID:
20139774
6.

Unmasking of alpha-fetoprotein-specific CD4(+) T cell responses in hepatocellular carcinoma patients undergoing embolization.

Ayaru L, Pereira SP, Alisa A, Pathan AA, Williams R, Davidson B, Burroughs AK, Meyer T, Behboudi S.

J Immunol. 2007 Feb 1;178(3):1914-22.

7.

Value of serum anti-p53 antibodies as a prognostic factor in Egyptian patients with hepatocellular carcinoma.

Atta MM, el-Masry SA, Abdel-Hameed M, Baiomy HA, Ramadan NE.

Clin Biochem. 2008 Oct;41(14-15):1131-9. doi: 10.1016/j.clinbiochem.2008.06.006. Epub 2008 Jun 20.

PMID:
18616935
8.

Cell-mediated immune responses to alpha-fetoprotein and other antigens in hepatocellular carcinoma.

Behboudi S, Boswell S, Williams R.

Liver Int. 2010 Apr;30(4):521-6. doi: 10.1111/j.1478-3231.2009.02194.x. Epub 2009 Dec 22. Review.

PMID:
20040052
9.

Cirrhotic patients with or without hepatocellular carcinoma harbour AFP-specific T-lymphocytes that can be activated in vitro by human alpha-fetoprotein.

Hanke P, Rabe C, Serwe M, Böhm S, Pagenstecher C, Sauerbruch T, Caselmann WH.

Scand J Gastroenterol. 2002 Aug;37(8):949-55.

PMID:
12229971
10.

Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection.

Kakumu S, Ito S, Ishikawa T, Mita Y, Tagaya T, Fukuzawa Y, Yoshioka K.

J Gastroenterol Hepatol. 2000 Apr;15(4):431-6.

PMID:
10824889
12.

Activation of cytotoxic and natural killer T-cell system in patients with hepatocellular carcinoma and cirrhosis.

Marafin C, Rinaldi M, Angonese C, De Franchis G, Plebani M, Naccarato R, Farinati F.

Ital J Gastroenterol. 1996 Dec;28(9):493-8.

PMID:
9131393
13.

Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer.

Butterfield LH, Ribas A, Potter DM, Economou JS.

Cancer Immunol Immunother. 2007 Dec;56(12):1931-43. Epub 2007 May 24.

PMID:
17522860
14.

Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.

Mizukoshi E, Nakamoto Y, Arai K, Yamashita T, Sakai A, Sakai Y, Kagaya T, Yamashita T, Honda M, Kaneko S.

Hepatology. 2011 Apr;53(4):1206-16. doi: 10.1002/hep.24149.

PMID:
21480325
15.

Clinical evaluation of serum alpha-fetoprotein-IgM immune complexes on the diagnosis of primary hepatocellular carcinoma.

Jingting J, Changping W, Ning X, yibei Z, Jun W, Mei J, Bin X, Peter NE, Xueguan Z.

J Clin Lab Anal. 2009;23(4):213-8. doi: 10.1002/jcla.20321.

PMID:
19623644
16.

Lentivirally engineered dendritic cells activate AFP-specific T cells which inhibit hepatocellular carcinoma growth in vitro and in vivo.

Liu Y, Butterfield LH, Fu X, Song Z, Zhang X, Lu C, Ding G, Wu M.

Int J Oncol. 2011 Jul;39(1):245-53. doi: 10.3892/ijo.2011.1004. Epub 2011 Apr 13.

17.

Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis.

Nguyen MH, Garcia RT, Simpson PW, Wright TL, Keeffe EB.

Hepatology. 2002 Aug;36(2):410-7.

PMID:
12143050
18.

AFP-specific CD4+ helper T-cell responses in healthy donors and HCC patients.

Evdokimova VN, Liu Y, Potter DM, Butterfield LH.

J Immunother. 2007 May-Jun;30(4):425-37.

19.

Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients.

Bei R, Budillon A, Reale MG, Capuano G, Pomponi D, Budillon G, Frati L, Muraro R.

Cancer Res. 1999 Nov 1;59(21):5471-4.

20.

CD4+ hepatic cancer-specific cytotoxic T lymphocytes in patients with hepatocellular carcinoma.

Nakao M, Sata M, Saitsu H, Yutani S, Kawamoto M, Kojiro M, Itoh K.

Cell Immunol. 1997 May 1;177(2):176-81.

PMID:
9178645
Items per page

Supplemental Content

Write to the Help Desk